News

The COVID-19 pandemic has deeply affected us all.

Fitbit's CEO James Park told CNBC that the company will be submitting its technology to the FDA soon. 

The new tech is designed to help curb face-to-face interactions during the coronavirus pandemic. 

The Philadelphia-based startup was designed to help patients with organizing their prescription medications and via online support. 

The tests give users the option to share information to aid national research into the virus.

Professor Wang Linfa, Director of the Duke-NUS’ Emerging Infectious Diseases programme, and team conceived this research and invented the cPass diagnostic test.

Singapore-based HeartVoice, which was formed in February 2019 as a joint venture between both iAPPS and Omron Healthcare, announced last week that it will extend the use of its telehealth platform to all healthcare providers for free in the country until 31 July, 2020.

Also: Intel, UPenn and others employ AI for brain tumor identification; DrChrono integrates EHRsynergy's documentation tool.

Eko's ECG low ejection fraction tool will now be able to help clinicians spot cardiac complications associated with the novel coronavirus. 

AI is steadily proving itself to the clinical community, but there are some aspects of care in which an algorithm will never be granted full control, said Cardiologs CEO Yann Fleureau.